{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:34:48Z","timestamp":1792085688332,"version":"4.4.0"},"reference-count":38,"publisher":"China Science Publishing & Media Ltd.","content-domain":{"domain":["engine.scichina.com"],"crossmark-restriction":false},"short-container-title":["ABBS"],"published-print":{"date-parts":[[2023,11,1]]},"DOI":"10.3724\/abbs.2023274","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T07:54:34Z","timestamp":1700553274000},"update-policy":"https:\/\/doi.org\/10.1360\/scp-crossmark-policy-page","source":"Crossref","is-referenced-by-count":8,"title":["HSFAS mediates fibroblast proliferation, migration, trans-differentiation and apoptosis in hypertrophic scars via interacting with ADAMTS8"],"prefix":"10.3724","author":[{"given":"Fang","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengchao","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinju","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangyong","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yideng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2026","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"CITATION1","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1089\/wound.2021.0028","volume":"11","author":"Menchaca AD","year":"2022","unstructured":"Menchaca AD, Style CC, Olutoye OO. A review of hypertrophic scar and keloid treatment and prevention in the pediatric population: where are we now?. Adv Wound Care, 2022, 11: 255-279.","journal-title":"Adv Wound Care"},{"key":"CITATION2","doi-asserted-by":"publisher","first-page":"110287","DOI":"10.1016\/j.biopha.2020.110287","volume":"129","author":"Zhang T","year":"2020","unstructured":"Zhang T, Wang XF, Wang ZC, Lou D, Fang QQ, Hu YY, Zhao WY. Current potential therapeutic strategies targeting the TGF-\u03b2\/Smad signaling pathway to attenuate keloid and hypertrophic scar formation. Biomed Pharmacother, 2020, 129:","journal-title":"Biomed Pharmacother"},{"key":"CITATION3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/s41419-021-03481-6","volume":"12","author":"He J","year":"2021","unstructured":"He J, Fang B, Shan S, Xie Y, Wang C, Zhang Y, Zhang X. Mechanical stretch promotes hypertrophic scar formation through mechanically activated cation channel Piezo1. Cell Death Dis, 2021, 12:","journal-title":"Cell Death Dis"},{"key":"CITATION4","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3390\/cells12050678","volume":"12","author":"Mony MP","year":"2023","unstructured":"Mony MP, Harmon KA, Hess R, Dorafshar AH, Shafikhani SH. An updated review of hypertrophic scarring. Cells, 2023, 12:","journal-title":"Cells"},{"key":"CITATION5","doi-asserted-by":"publisher","first-page":"123809","DOI":"10.1016\/j.ijbiomac.2023.123809","volume":"235","author":"Li J","year":"2023","unstructured":"Li J, Yin Y, Zhang E, Gui M, Chen L, Li J. Peptide deregulated in hypertrophic scar-1 alleviates hypertrophic scar fibrosis by targeting focal adhesion kinase and pyruvate kinase M2 and remodeling the metabolic landscape. Int J Biol Macromolecules, 2023, 235:","journal-title":"Int J Biol Macromolecules"},{"key":"CITATION6","doi-asserted-by":"publisher","first-page":"7601","DOI":"10.1021\/acsnano.7b07439","volume":"12","author":"Weng W","year":"2018","unstructured":"Weng W, He S, Song H, Li X, Cao L, Hu Y, Cui J. Aligned carbon nanotubes reduce hypertrophic scar                          via regulating cell behavior. ACS Nano, 2018, 12: 7601-7612.","journal-title":"ACS Nano"},{"key":"CITATION7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s12951-023-01861-y","volume":"21","author":"Han F","year":"2023","unstructured":"Han F, Wang K, Shen K, Wang J, Han S, Hu D, Wu G. Extracellular vesicles from                          Lactobacillus druckerii inhibit hypertrophic scar fibrosis. J Nanobiotechnol, 2023, 21:","journal-title":"J Nanobiotechnol"},{"key":"CITATION8","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1038\/s41580-021-00447-6","volume":"23","author":"Nojima T","year":"2022","unstructured":"Nojima T, Proudfoot NJ. Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics. Nat Rev Mol Cell Biol, 2022, 23: 389-406.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"CITATION9","doi-asserted-by":"publisher","first-page":"1054827","DOI":"10.3389\/fendo.2022.1054827","volume":"13","author":"Zhang D","year":"2022","unstructured":"Zhang D, Xue J, Peng F. The regulatory activities of MALAT1 in the development of bone and cartilage diseases. Front Endocrinol, 2022, 13:","journal-title":"Front Endocrinol"},{"key":"CITATION10","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1038\/s41418-021-00792-1","volume":"28","author":"Sun J","year":"2021","unstructured":"Sun J, Jin T, Su W, Guo Y, Niu Z, Guo J, Li L. The long non-coding RNA PFI protects against pulmonary fibrosis by interacting with splicing regulator SRSF1. Cell Death Differ, 2021, 28: 2916-2930.","journal-title":"Cell Death Differ"},{"key":"CITATION11","doi-asserted-by":"publisher","first-page":"115627","DOI":"10.1016\/j.bcp.2023.115627","volume":"213","author":"Hjazi A","year":"2023","unstructured":"Hjazi A, Ghaffar E, Asghar W, Alauldeen Khalaf H, Ikram Ullah M, Mireya Romero-Parra R, Hussien BM. CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective. Biochem Pharmacol, 2023, 213:","journal-title":"Biochem Pharmacol"},{"key":"CITATION12","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1016\/j.omtn.2020.01.008","volume":"19","author":"Liu C","year":"2020","unstructured":"Liu C, Peng Z, Li P, Fu H, Feng J, Zhang Y, Liu T. lncRNA RMST suppressed GBM cell mitophagy through enhancing FUS SUMOylation. Mol Ther Nucleic Acids, 2020, 19: 1198-1208.","journal-title":"Mol Ther Nucleic Acids"},{"key":"CITATION13","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1016\/j.apsb.2022.04.006","volume":"12","author":"Sun J","year":"2022","unstructured":"Sun J, Jin T, Niu Z, Guo J, Guo Y, Yang R, Wang Q. LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation. Acta Pharmaceutica Sin B, 2022, 12: 3602-3617.","journal-title":"Acta Pharmaceutica Sin B"},{"key":"CITATION14","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.canlet.2020.11.006","volume":"500","author":"Shermane Lim YW","year":"2021","unstructured":"Shermane Lim YW, Xiang X, Garg M, Le MT, Li-Ann Wong A, Wang L, Goh BC. The double-edged sword of H19 lncRNA: insights into cancer therapy. Cancer Lett, 2021, 500: 253-262.","journal-title":"Cancer Lett"},{"key":"CITATION15","doi-asserted-by":"crossref","unstructured":"Fan P, Wang Y, Li J, Fang M. lncRNA PAPPA-AS1 induces the development of hypertrophic scar by upregulating TLR4 through interacting with TAF15.                                                       Mediators Inflamm                          2021, 2021: 3170261.","DOI":"10.1155\/2021\/3170261"},{"key":"CITATION16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/cac2.12108","volume":"41","author":"Tan YT","year":"2021","unstructured":"Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA\u2010mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Commun, 2021, 41: 109-120.","journal-title":"Cancer Commun"},{"key":"CITATION17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-pathol-042320-115255","volume":"17","author":"DiStefano JK","year":"2022","unstructured":"DiStefano JK, Gerhard GS. Long noncoding RNAs and human liver disease. Annu Rev Pathol Mech Dis, 2022, 17: 1-21.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"CITATION18","doi-asserted-by":"publisher","first-page":"274","DOI":"10.3724\/abbs.2022122","volume":"55","author":"Ma F","year":"2022","unstructured":"Ma F, Shen J, Zhang H, Zhang Z, Yang A, Xiong J, Jiao Y. A novel lncRNA FPASL regulates fibroblast proliferation via the PI3K\/AKT and MAPK signaling pathways in hypertrophic scar. Acta Biochim Biophys Sin, 2022, 55: 274-284.","journal-title":"Acta Biochim Biophys Sin"},{"key":"CITATION19","doi-asserted-by":"publisher","first-page":"2207888","DOI":"10.1002\/smll.202207888","volume":"19","author":"Ji Z","year":"2023","unstructured":"Ji Z, Zheng J, Ma Y, Lei H, Lin W, Huang J, Yang H. Emergency treatment and photoacoustic assessment of spinal cord injury using reversible dual-signal transform-based selenium antioxidant. Small, 2023, 19:","journal-title":"Small"},{"key":"CITATION20","doi-asserted-by":"publisher","first-page":"2252","DOI":"10.1016\/j.molcel.2022.05.027","volume":"82","author":"Herman AB","year":"2022","unstructured":"Herman AB, Tsitsipatis D, Gorospe M. Integrated lncRNA function upon genomic and epigenomic regulation. Mol Cell, 2022, 82: 2252-2266.","journal-title":"Mol Cell"},{"key":"CITATION21","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.semcancer.2022.05.013","volume":"86","author":"Shaath H","year":"2022","unstructured":"Shaath H, Vishnubalaji R, Elango R, Kardousha A, Islam Z, Qureshi R, Alam T. Long non-coding RNA and RNA-binding protein interactions in cancer: Experimental and machine learning approaches. Semin Cancer Biol, 2022, 86: 325-345.","journal-title":"Semin Cancer Biol"},{"key":"CITATION22","doi-asserted-by":"publisher","first-page":"101323","DOI":"10.1016\/j.jbc.2021.101323","volume":"297","author":"Santamaria S","year":"2021","unstructured":"Santamaria S, Martin DR, Dong X, Yamamoto K, Apte SS, Ahnstr\u00f6m J. Post-translational regulation and proteolytic activity of the metalloproteinase ADAMTS8. J Biol Chem, 2021, 297:","journal-title":"J Biol Chem"},{"key":"CITATION23","doi-asserted-by":"publisher","first-page":"1028410","DOI":"10.3389\/fimmu.2022.1028410","volume":"13","author":"Yin J","year":"2022","unstructured":"Yin J, Zhang S, Yang C, Wang Y, Shi B, Zheng Q, Zeng N. Mechanotransduction in skin wound healing and scar formation: potential therapeutic targets for controlling hypertrophic scarring. Front Immunol, 2022, 13:","journal-title":"Front Immunol"},{"key":"CITATION24","doi-asserted-by":"publisher","first-page":"tkac027","DOI":"10.1093\/burnst\/tkac027","volume":"10","author":"Wang J","year":"2022","unstructured":"Wang J, Shang R, Yang J, Liu Z, Chen Y, Chen C, Zheng W. P311 promotes type II transforming growth factor-\u03b2 receptor mediated fibroblast activation and granulation tissue formation in wound healing. Burns Trauma, 2022, 10:","journal-title":"Burns Trauma"},{"key":"CITATION25","doi-asserted-by":"publisher","first-page":"1207522","DOI":"10.3389\/fimmu.2023.1207522","volume":"14","author":"Song B","year":"2023","unstructured":"Song B, Liu W, Zhu Y, Peng Y, Cui Z, Gao B, Chen L. Deciphering the contributions of cuproptosis in the development of hypertrophic scar using single-cell analysis and machine learning techniques. Front Immunol, 2023, 14:","journal-title":"Front Immunol"},{"key":"CITATION26","doi-asserted-by":"publisher","first-page":"113753","DOI":"10.1016\/j.biopha.2022.113753","volume":"155","author":"Kuang Y","year":"2022","unstructured":"Kuang Y, Shen W, Zhu H, Huang H, Zhou Q, Yin W, Zhou Y. The role of lncRNA just proximal to XIST (JPX) in human disease phenotypes and RNA methylation: the novel biomarker and therapeutic target potential. Biomed Pharmacother, 2022, 155:","journal-title":"Biomed Pharmacother"},{"key":"CITATION27","doi-asserted-by":"publisher","first-page":"bbab504","DOI":"10.1093\/bib\/bbab504","volume":"23","author":"Park EG","year":"2022","unstructured":"Park EG, Pyo SJ, Cui Y, Yoon SH, Nam JW. Tumor immune microenvironment lncRNAs. Brief BioInf, 2022, 23:","journal-title":"Brief BioInf"},{"key":"CITATION28","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s11010-020-03966-6","volume":"476","author":"Li Q","year":"2021","unstructured":"Li Q, Chen X, Chen L, Yan H, Li J. LINC00173 promotes the apoptosis of hypertrophic scar fibroblasts through increasing \u03b2-catenin expression. Mol Cell Biochem, 2021, 476: 1005-1014.","journal-title":"Mol Cell Biochem"},{"key":"CITATION29","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1186\/s12864-021-07920-8","volume":"22","author":"Gu S","year":"2021","unstructured":"Gu S, Huang X, Xu X, Liu Y, Khoong Y, Zhang Z, Li H. Inhibition of CUB and sushi multiple domains 1 (CSMD1) expression by miRNA-190a-3p enhances hypertrophic scar-derived fibroblast migration                          in vitro. BMC Genomics, 2021, 22:","journal-title":"BMC Genomics"},{"key":"CITATION30","doi-asserted-by":"publisher","first-page":"5989","DOI":"10.2147\/IJN.S196794","volume":"Volume 14","author":"Xiao Y","year":"2019","unstructured":"Xiao Y, Xu D, Song H, Shu F, Wei P, Yang X, Zhong C. Cuprous oxide nanoparticles reduces hypertrophic scarring by inducing fibroblast apoptosis. IJN, 2019, Volume 14: 5989-6000.","journal-title":"IJN"},{"key":"CITATION31","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/j.ijbiomac.2020.03.161","volume":"154","author":"Zhang N","year":"2020","unstructured":"Zhang N, Gao T, Wang Y, Liu J, Zhang J, Yao R, Wu F. Modulating cationicity of chitosan hydrogel to prevent hypertrophic scar formation during wound healing. Int J Biol Macromolecules, 2020, 154: 835-843.","journal-title":"Int J Biol Macromolecules"},{"key":"CITATION32","doi-asserted-by":"publisher","first-page":"21662","DOI":"10.1002\/jcp.28830","volume":"234","author":"Yuan FL","year":"2019","unstructured":"Yuan FL, Sun ZL, Feng Y, Liu SY, Du Y, Yu S, Yang ML. Epithelial-mesenchymal transition in the formation of hypertrophic scars and keloids. J Cell Physiol, 2019, 234: 21662-21669.","journal-title":"J Cell Physiol"},{"key":"CITATION33","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/bjd.18219","volume":"182","author":"Limandjaja GC","year":"2020","unstructured":"Limandjaja GC, Belien JM, Scheper RJ, Niessen FB, Gibbs S. Hypertrophic and keloid scars fail to progress from the CD 34                         \u2212\/\u03b1\u2010smooth muscle actin (\u03b1\u2010SMA )                         + immature scar phenotype and show gradient differences in \u03b1\u2010SMA and p16 expression. Br J Dermatol, 2020, 182: 974-986.","journal-title":"Br J Dermatol"},{"key":"CITATION34","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1002\/cac2.12254","volume":"42","author":"Yao ZT","year":"2022","unstructured":"Yao ZT, Yang YM, Sun MM, He Y, Liao L, Chen KS, Li B. New insights into the interplay between long non\u2010coding RNAs and RNA\u2010binding proteins in cancer. Cancer Commun, 2022, 42: 117-140.","journal-title":"Cancer Commun"},{"key":"CITATION35","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41556-022-00911-1","volume":"24","author":"Unfried JP","year":"2022","unstructured":"Unfried JP, Ulitsky I. Substoichiometric action of long noncoding RNAs. Nat Cell Biol, 2022, 24: 608-615.","journal-title":"Nat Cell Biol"},{"key":"CITATION36","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/s12943-022-01578-w","volume":"21","author":"Yuan K","year":"2022","unstructured":"Yuan K, Lan J, Xu L, Feng X, Liao H, Xie K, Wu H. Long noncoding RNA TLNC1 promotes the growth and metastasis of liver cancer via inhibition of p53 signaling. Mol Cancer, 2022, 21:","journal-title":"Mol Cancer"},{"key":"CITATION37","doi-asserted-by":"publisher","first-page":"127640","DOI":"10.1016\/j.chemosphere.2020.127640","volume":"261","author":"Li J","year":"2020","unstructured":"Li J, Quan X, Chen G, Hong J, Wang Q, Xu L, Wang B. PFOS-induced placental cell growth inhibition is partially mediated by lncRNA H19 through interacting with miR-19a and miR-19b. Chemosphere, 2020, 261:","journal-title":"Chemosphere"},{"key":"CITATION38","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1161\/CIRCRESAHA.119.315398","volume":"125","author":"Omura J","year":"2019","unstructured":"Omura J, Satoh K, Kikuchi N, Satoh T, Kurosawa R, Nogi M, Ohtsuki T. ADAMTS8 promotes the development of pulmonary arterial hypertension and right ventricular failure. Circ Res, 2019, 125: 884-906.","journal-title":"Circ Res"}],"container-title":["Acta Biochimica et Biophysica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/74D278799BC2476F9480B3AE09941EBE","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023274","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/engine.scichina.com\/doi\/pdf\/74D278799BC2476F9480B3AE09941EBE","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T08:27:49Z","timestamp":1700814469000},"score":1,"resource":{"primary":{"URL":"https:\/\/engine.scichina.com\/doi\/10.3724\/abbs.2023274"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":38,"URL":"https:\/\/doi.org\/10.3724\/abbs.2023274","relation":{},"ISSN":["1672-9145"],"issn-type":[{"value":"1672-9145","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,1]]}}}